Michihito Onishi
Direttore/Membro del Consiglio presso HISHOH Biopharma Co., Ltd.
Provenienza dei contatti di primo grado di Michihito Onishi
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
HISHOH Biopharma Co., Ltd.
 HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michihito Onishi tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Cellusion Inc.
 Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Miscellaneous Commercial Services | Director/Board Member | |
| Wake Forest University | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Giappone | 2 |
| Stati Uniti | 2 |
Settori
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni
| Director/Board Member | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Toru Seo | 3 |
| Naoki Sakurai | 1 |
- Borsa valori
- Insiders
- Michihito Onishi
- Connessioni Società
